Is Mediterranean diet associated with multiple sclerosis related symptoms and fatigue severity?

References

• Ünal A, Mavioğlu H, Altunrende B, İçen NK, Ergün U. Multipl Sklerozda Tanı ve Ayırıcı Tanı. In: Efendi H, Kuşcu DY, editor. Multipl Skleroz Tanı ve Tedavi Kılavuzu. İstanbul: Galenos yayınevi; 2018. p. 9.
   Google Scholar
• de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, et al. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord. 2011;4(3):139–68.
   PubMedGoogle Scholar
• Marrie R, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010;74(13):1041–7.
   PubMed Web of Science ®Google Scholar
• Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015;128(3):229–38.
   PubMed Web of Science ®Google Scholar
• Mendez MA, Popkin BM, Jakszyn P, Berenguer A, Tormo MJ, Sanchéz MJ, et al. Adherence to a Mediterranean diet is associated with reduced 3-year incidence of obesity. J Nutr. 2006;136(11):2934–8.
   PubMed Web of Science ®Google Scholar
• Romaguera D, Norat T, Vergnaud A-C, Mouw T, May AM, Agudo A, et al. Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project. Am J Clin Nutr. 2010;92(4):912–21.
   PubMed Web of Science ®Google Scholar
• Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord. 2019;36:101393.
   PubMed Web of Science ®Google Scholar
• Mische LJ, Mowry EM. The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review. Curr Treat Options Neurol. 2018;20(4):8.
   PubMed Web of Science ®Google Scholar
• Dernini S, Berry EM, Serra-Majem L, La Vecchia C, Capone R, Medina F, et al. Med Diet 4.0: the Mediterranean diet with four sustainable benefits. Public Health Nutr. 2017;20(7):1322–30.
   PubMed Web of Science ®Google Scholar
• Katz Sand I, Benn EKT, Fabian M, Fitzgerald KC, Digga E, Deshpande R, et al. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2019;36:101403.
   PubMed Web of Science ®Google Scholar
• Moravejolahkami AR, Paknahad Z, Chitsaz A. Association of dietary patterns with systemic inflammation, quality of life, disease severity, relapse rate, severity of fatigue and anthropometric measurements in MS patients. Nutr Neurosci. 2020;23(12):920–30.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology. 2018;90(1):1–11.
   PubMed Web of Science ®Google Scholar
• Martínez-González MA, García-Arellano A, Toledo E, Salas-Salvado J, Buil-Cosiales P, Corella D, et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PloS one. 2012;7(8):e43134.
   PubMed Web of Science ®Google Scholar
• Schröder H, Fitó M, Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011;141(6):1140–5.
   PubMed Web of Science ®Google Scholar
• Özkan-Pehlivanoğlu EF, Balcıoğlu H, Ünlüoğlu İ. Turkish Validation and Reliability of Mediterranean Diet Adherence Screener. Osmangazi Journal of Medicine. 2020;42(2):160–4.
   Google Scholar
• Gulick EE. Model confirmation of the MS-related symptom checklist. Nurs Res. 1989;38(3):147–53.
   PubMed Web of Science ®Google Scholar
• Tulek Z, Polat C, Kurtuncu M, Eraksoy M. Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist. Noro Psikiyatr Ars. 2017;54(4):328–33.
   PubMedGoogle Scholar
• Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435–7.
   PubMed Web of Science ®Google Scholar
• Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007;30(1):81–5.
   PubMed Web of Science ®Google Scholar
• Munoz MA, Fito M, Marrugat J, Covas MI, Schroder H, Regicor, et al. Adherence to the Mediterranean diet is associated with better mental and physical health. Br J Nutr. 2009;101(12):1821-7.
   PubMed Web of Science ®Google Scholar
• Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci. 2015;18(3):125–36.
   PubMed Web of Science ®Google Scholar
• Black LJ, Baker K, Ponsonby AL, van der Mei I, Lucas RM, Pereira G, et al. A Higher Mediterranean Diet Score, Including Unprocessed Red Meat, Is Associated with Reduced Risk of Central Nervous System Demyelination in a Case-Control Study of Australian Adults. J Nutr. 2019;149(8):1385–92.
   PubMed Web of Science ®Google Scholar
• Hebestreit K, Yahiaoui-Doktor M, Engel C, Vetter W, Siniatchkin M, Erickson N, et al. Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire. BMC Cancer. 2017;7(1):341.
   Google Scholar
• Gutierrez S, Svahn SL, Johansson ME. Effects of Omega-3 Fatty Acids on Immune Cells. Int J Mol Sci. 2019;20:20.
   Web of Science ®Google Scholar
• AlAmmar WA, Albeesh FH, Ibrahim LM, Algindan YY, Yamani LZ, Khattab RY. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci. 2019: 1–11.
   Web of Science ®Google Scholar
• Da Costa Silva BY, De Carvalho Sampaio HA, Shivappa N, Hebert J, Silva Albuquerque LD, Ferreira Carioca AA, et al. Interactions between dietary inflammatory index, nutritional state and Multiple Sclerosis clinical condition. Clin Nutr ESPEN. 2018;26:35–41.
   PubMed Web of Science ®Google Scholar
• Weiland TJ, De Livera AM, Brown CR, Jelinek GA, Aitken Z, Simpson SL, Jr., et al. Health Outcomes and Lifestyle in a Sample of People With Multiple Sclerosis (HOLISM): Longitudinal and Validation Cohorts. Front Neurol. 2018;9:1074.
   PubMed Web of Science ®Google Scholar
• Bagur MJ, Murcia MA, Jimenez-Monreal AM, Tur JA, Bibiloni MM, Alonso GL, et al. Influence of Diet in Multiple Sclerosis: A Systematic Review. Adv Nutr. 2017;8(3):463–72.
   PubMed Web of Science ®Google Scholar
• Pommerich UM, Brincks J, Christensen ME. Is there an effect of dietary intake on MS-related fatigue?–A systematic literature review. Mult Scler Relat Disord. 2018;25:282–91.
   PubMed Web of Science ®Google Scholar
• Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord. 2016;9:80–90.
   PubMed Web of Science ®Google Scholar
• Fellows Maxwell K, Wahls T, Browne RW, Rubenstein L, Bisht B, Chenard CA, et al. Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. PLoS One. 2019;14(6):e0218075.
   PubMed Web of Science ®Google Scholar
• Bisht B, Darling WG, Shivapour ET, Lutgendorf SK, Snetselaar LG, Chenard CA, et al. Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2015;5:19–35.
   PubMedGoogle Scholar
• Mousavi-Shirazi-Fard Z, Mazloom Z, Izadi S, Fararouei M. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial. International Journal of Neuroscience. 2020: 1–9.
   Web of Science ®Google Scholar
• Albrechtsen MT, Langeskov-Christensen M, Jorgensen MLK, Dalgas U, Hansen M. Is diet associated with physical capacity and fatigue in persons with multiple sclerosis? -Results from a pilot study. Mult Scler Relat Disord. 2020;40:101921.
   PubMed Web of Science ®Google Scholar
• Weiland TJ, Jelinek GA, Marck CH, Hadgkiss EJ, van der Meer DM, Pereira NG, et al. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One. 2015;10(2):e0115541.
   PubMed Web of Science ®Google Scholar
• Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Multiple Sclerosis Journal. 2020;26(14):1816–21.
   PubMed Web of Science ®Google Scholar